ReviewNorth American journal of medical sciences2014

Canagliflozin: A Novel SGLT2 Inhibitor for Type 2 Diabetes Mellitus.

Shaveta Kaushal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.